Alliance, Molecular Biosystems deal

ALLP will acquire MBIO for 770,000 ALLP shares, valuing MBIO at about $11 million using ALLP’s Friday closing price of $14.25. MBIO’s Optison intravenous ultrasound contrast agent is sold in the U.S....